Introduction. Colorectal cancer (CRC) is one of the most common cancers worldwide. Multiple risk factors are involved in CRC development, including age, genetics, lifestyle, diet and environment. Of these, the role of the gut microbiota in cancer biology is increasingly recognized.
Hypothesis/Gap Statement. Micro-organisms have been widely detected in stool samples, but few mucosal samples have been detected and sequenced in depth.
Aim. Analysis of cultured mucosal bacteria from colorectal cancer and adjacent normal mucosal tissues with metagenomics sequencing.
Methodology. Twenty-eight paired tumour and non-tumour tissues from 14 patients undergoing surgery for CRC were analysed. We removed the influence of eukaryotic cells via culture. The composition of mucosal microbiota in intestinal mucosa were detected and analysed with metagenomic sequencing.
Results. Compared with non-cultured mucosal sample, 80 % bacteria species could be detected after culture. Moreover, after culture, additional 30 % bacteria could be detected, compared with non-cultured samples. Since after culture it was difficult to estimate the original abundance of microbiome, we focused on the identification of the CRC tissue-specific species. There were 298 bacterial species, which could only be cultured and detected in CRC tissues. Myroides odoratimimus and Cellulophaga baltica could be isolated from all the tumour samples of 14 CRC patients, suggesting that these species may be related to tumour occurrence and development. Further functional analysis indicated that bacteria from CRC tissues showed more active functions, including basic metabolism, signal transduction and survival activities.
Conclusion. We used a new method based on culture to implement information on prokaryotic taxa, and related functions, which samples were from colorectal tissues. This method is suitable for removing eukaryotic contamination and detecting micro-organisms from other tissues.
ArnoldM, SierraMS, LaversanneM, SoerjomataramI, JemalA et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut2017; 66:683–691 [View Article] [PubMed]
AhnJ, SinhaR, PeiZ, DominianniC, WuJ et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst2013; 105:1907–1911 [View Article] [PubMed]
ZackularJP, BaxterNT, ChenGY, SchlossPD et al. Manipulation of the gut microbiota reveals role in colon tumorigenesis. mSphere2016; 1:e00001-15 [View Article] [PubMed]
FengQ, LiangS, JiaH, StadlmayrA, TangL et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun2015; 6:6528 [View Article] [PubMed]
YuJ, FengQ, WongSH, ZhangD, LiangQY et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut2017; 66:70–78 [View Article] [PubMed]
JohnsonCM, WeiC, EnsorJE, SmolenskiDJ, AmosCI et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control2013; 24:1207–1222 [View Article] [PubMed]
HuxleyRR, Ansary-MoghaddamA, CliftonP, CzernichowS, ParrCL et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer2009; 125:171–180 [View Article] [PubMed]
ZhuW, MiyataN, WinterMG, ArenalesA, HughesER et al. Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer. J Exp Med2019; 216:2378–2393 [View Article] [PubMed]
LokeMF, ChuaEG, GanHM, ThulasiK, WanyiriJW et al. Metabolomics and 16S rRNA sequencing of human colorectal cancers and adjacent mucosa. PLoS One2018; 13:e0208584 [View Article] [PubMed]
LagierJ-C, KhelaifiaS, AlouMT, NdongoS, DioneN et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol2016; 1:16203 [View Article] [PubMed]
TjalsmaH, BoleijA, MarchesiJR, DutilhBE et al. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol2012; 10:575–582 [View Article] [PubMed]
VancanneytM, SegersP, TorckU, HosteB, BernardetJ-F et al. Reclassification of Flavobacterium odoratum (Stutzer 1929) strains to a new genus, Myroides, as Myroides odoratus comb. nov. and Myroides odoratimimus sp. nov. Int J Syst Bacteriol1996; 46:926–932 [View Article]
BenedettiP, RassuM, PavanG, SeftonA, PellizzerG et al. Septic shock, pneumonia, and soft tissue infection due to Myroides odoratimimus: report of a case and review of Myroides infections. Infection2011; 39:161–165 [View Article] [PubMed]
MarakiS, SarchianakiE, BarbagadakisS. Myroides odoratimimus soft tissue infection in an immunocompetent child following a pig bite: case report and literature review. Braz J Infect Dis2012; 16:390–392 [View Article] [PubMed]
KtariS, MnifB, KoubaaM, MahjoubiF, Ben JemaaM et al. Nosocomial outbreak of Myroides odoratimimus urinary tract infection in a Tunisian hospital. J Hosp Infect2012; 80:77–81 [View Article] [PubMed]
JohansenJE, NielsenP, SjøholmC. Description of Cellulophaga baltica gen. nov., sp. nov. and Cellulophaga fucicola gen. nov., sp. nov. and reclassification of [Cytophaga] lytica to Cellulophaga lytica gen. nov., comb. nov. Int J Syst Bacteriol1999; 49 Pt 3:1231–1240 [View Article]
HolmfeldtK, MiddelboeM, NybroeO, RiemannL et al. Large variabilities in host strain susceptibility and phage host range govern interactions between lytic marine phages and their Flavobacterium hosts. Appl Environ Microbiol2007; 73:6730–6739 [View Article] [PubMed]
DangVT, Howard-VaronaC, SchwenckS, SullivanMB et al. Variably lytic infection dynamics of large Bacteroidetes podovirus phi38:1 against two Cellulophaga baltica host strains. Environ Microbiol2015; 17:4659–4671 [View Article] [PubMed]
RamosKRM, ValdehuesaKNG, NisolaGM, LeeW-K, ChungW-J et al. Identification and characterization of a thermostable endolytic β-agarase Aga2 from a newly isolated marine agarolytic bacteria Cellulophaga omnivescoria W5C. N Biotechnol2018; 40:261–267 [View Article] [PubMed]